Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Corteva lifts sales forecast on strong demand for crop protection products, seeds

Published 08/05/2021, 05:14 PM
Updated 08/05/2021, 05:55 PM
© Reuters. The logo and trading info for Corteva Agriscience, a former division of DowDuPont, is displayed on a screen at the New York Stock Exchange (NYSE) in New York, U.S., June 3, 2019. REUTERS/Brendan McDermid/Files
CTVA
-

(Reuters) - Corteva (NYSE:CTVA) Inc on Thursday raised its net sales forecast for the year after strong demand for crop protection products such as herbicides and insecticides helped the agricultural company beat estimates for the second quarter.

Corteva also announced a new $1.5 billion share repurchase program, in addition to a $1 billion buyback announced in 2019, which the company expects to complete by the end of 2021.

The company's shares rose 3.7% to $43.00 in extended trade.

Last month, it increased its common stock dividend by 7.7% to 14 cents per share.

The company, spun off in 2019 after a merger of Dow Chemical and Dupont, has laid off employees and retired some assets to cut costs. Last month, it said Chief Executive Officer James Collins Jr will retire, months after activist investor Starboard Value LP sought to oust him.

Corteva forecast 2021 net sales between $15.2 billion and $15.4 billion, versus an earlier estimate of $14.6 billion to $14.8 billion. Analysts were expecting $14.82 billion, according to Refinitiv IBES.

Net sales rose 8.4% to $5.63 billion in the second quarter, surpassing an estimate of $5.33 billion, while total crop protection sales jumped about 12% to $1.85 billion due to demand for its new products including Arylex herbicide and Pyraxalt insecticide.

Seed sales rose 7% to $3.78 billion in the quarter thanks to increased soybean acreage in North America and higher volumes on the back of more normalized delivery timing in the region.

© Reuters. The logo and trading info for Corteva Agriscience, a former division of DowDuPont, is displayed on a screen at the New York Stock Exchange (NYSE) in New York, U.S., June 3, 2019. REUTERS/Brendan McDermid/Files

The Wilmington, Delaware-based company said operating earnings per share rose to $1.04 billion, or $1.40 per share, in the quarter ended June 30, from $944 million, or $1.26 per share, last year.

Analysts on average had expected a profit of $1.26 per share.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.